CoreWeave heads into its first earnings release as a public company with short sellers in retreat and analysts raising targets across the board.
The stock has surged 53% over the past month to $125.43, with an 12% gain just in the last week. Short interest has been drifting lower — down 4% over the past month to 14.7% of the float — and borrow availability remains ample. The cost to borrow has eased 17% over the week to a modest 0.37%, and the borrow market is loose enough that there is no meaningful squeeze pressure heading into the print. Options traders are leaning slightly bullish: the put/call ratio has dipped to 0.83, around 1.3 standard deviations below its 20-day average of 0.87, near the most call-heavy reading of the past year. That combination — shorts covering, cheap borrow, calls dominating — points to a market positioned for good news rather than braced for disappointment.
The analyst community has moved almost unanimously in one direction. Citi lifted its target from $126 to $155 on May 1, keeping a Buy rating, while Oppenheimer and Wells Fargo both raised targets in the days prior. Wolfe Research initiated at Outperform with a $150 target in mid-April. The lone dissonant voice is Bernstein, maintaining Underperform — though even Bernstein lifted its target from $56 to $67. The mean target across the Street now sits at $130, within striking distance of the current price. The bull case centers on CoreWeave's differentiated position in AI infrastructure: a $21B deal with Meta and the acquisition of Weights & Biases signal durable enterprise demand. Bears point to heavy customer concentration and the capital intensity of the build-out, arguing that the high CapEx burden leaves little room for execution missteps in a fiercely competitive IaaS market.
The insider picture adds a note of caution. Magnetar Financial, the largest institutional holder with an 11% stake, sold roughly $70M worth of shares on May 1 at prices around $119–$121 — just as the stock was rallying. CEO Michael Intrator, however, added 2.65M shares in late April, a meaningful vote of confidence from inside the house. The divergence between a large institutional holder trimming and the CEO buying is worth watching. Earnings history is limited for a newly public company, but the one data point available is stark: after the February 2026 release, the stock fell 19% in a single session and shed 24% over the following five days.
Thursday's print is therefore a test of whether CoreWeave's revenue trajectory and early margin signals can sustain a valuation that has already moved sharply ahead of the analyst consensus.
See the live data behind this article on ORTEX.
Open CRWV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
